Mackenzie Financial’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Mackenzie Financial’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,338	Closed	-$28.1K	–	1705
2024 Q2	$28.1K	Buy	+12,338	New	+$47.1K	﹤0.01%	1513
2023 Q1	–	Sell	-77,450	Closed	-$421K	–	1628
2022 Q4	$421K	Buy	+77,450	New	+$649K	﹤0.01%	987

Mackenzie Financial's GTHX Position: Q3 2024 in Review

Mackenzie Financial sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 12,338 shares — an estimated $28.1K sold.

Mackenzie Financial first reported a position in GTHX in Q4 2022 and held it in 2 quarters. The position peaked at $421K in Q4 2022. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Mackenzie Financial reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Mackenzie Financial sold 12,338 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $28.1K.
Mackenzie Financial first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Mackenzie Financial's G1 Therapeutics, Inc. Common Stock position peaked at $421K in Q4 2022.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Mackenzie Financial's 13F filing for Q3 2024, filed 13 Nov 2024.